These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26103821)

  • 1. [Encephalopathy in HIV patients on antiretroviral therapy].
    Kishida S
    Rinsho Shinkeigaku; 2015; 55(6):435-6. PubMed ID: 26103821
    [No Abstract]   [Full Text] [Related]  

  • 2. [Response regarding "HIV encephalopathy due to drug resistance despite 2-year suppression of HIV viremia by cART"].
    Sekiya H; Kawamoto M; Togo M; Yoshimura H; Imai Y; Kohara N
    Rinsho Shinkeigaku; 2015; 55(6):437. PubMed ID: 26103822
    [No Abstract]   [Full Text] [Related]  

  • 3. [HIV encephalopathy due to drug resistance despite 2-year suppression of HIV viremia by cART].
    Sekiya H; Kawamoto M; Togo M; Yoshimura H; Imai Y; Kohara N
    Rinsho Shinkeigaku; 2014; 54(9):721-5. PubMed ID: 25283826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HIV-1 viremia or sexually transmitted infection on semen-derived anti-HIV-1 antibodies and the immunosuppressive capacity of seminal plasma.
    Selva KJ; Bavinton BR; Grulich AE; Pazgier M; Kelleher AD; Kent SJ; Parsons MS
    Eur J Immunol; 2019 Dec; 49(12):2255-2258. PubMed ID: 31621073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy.
    Guerveno C; Raymond S; Metsu D; Gandia P; Izopet J; Martin-Blondel G; Delobel P
    AIDS; 2019 Mar; 33(3):593-594. PubMed ID: 30702524
    [No Abstract]   [Full Text] [Related]  

  • 6. Pretreatment antiretroviral exposure from recreational use.
    Grelotti DJ; Closson EF; Mimiaga MJ
    Lancet Infect Dis; 2013 Jan; 13(1):10-2. PubMed ID: 23257221
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropharmacology.
    Winston A; Manji H
    Handb Clin Neurol; 2018; 152():55-64. PubMed ID: 29604984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.
    Boyd A; Meynard JL; Morand-Joubert L; Michon A; Boccara F; Bastard JP; Samri A; Haddour N; Mallat Z; Capeau J; Desvarieux M; Girard PM;
    PLoS One; 2014; 9(11):e113876. PubMed ID: 25415323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution?
    Cattaneo D; Giacomelli A; Gervasoni C
    Obesity (Silver Spring); 2018 Aug; 26(8):1251-1252. PubMed ID: 30070075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.
    Bingham R; Ahmed N; Rangi P; Johnson M; Tyrer M; Green J
    Int J STD AIDS; 2011 Oct; 22(10):608-9. PubMed ID: 21998185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the glass three-quarters full or one-quarter empty?
    McArthur JC; Letendre SL
    J Infect Dis; 2006 Dec; 194(12):1628-31. PubMed ID: 17109332
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral therapy: treatment-experienced individuals.
    Calvo KR; Daar ES
    Infect Dis Clin North Am; 2014 Sep; 28(3):439-56. PubMed ID: 25151565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 30 years after HIV identification: where to from here?
    Stover J
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):947-9. PubMed ID: 22029511
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial commentary: cerebrospinal fluid inhibitory quotients of antiretroviral drugs.
    Fletcher CV
    Clin Infect Dis; 2015 Jan; 60(2):318-20. PubMed ID: 25281611
    [No Abstract]   [Full Text] [Related]  

  • 15. Baseline antiretroviral resistance and clinical outcomes in an urban HIV clinic.
    Klibanov OM; Dolder CR; Assefa F; Ekwonu TJ
    AIDS Patient Care STDS; 2013 Apr; 27(4):205-7. PubMed ID: 23514132
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.
    Streeck H; Jessen H; Alter G; Teigen N; Waring MT; Jessen A; Stahmer I; van Lunzen J; Lichterfeld M; Gao X; Allen TM; Carrington M; Walker BD; Rockstroh JK; Altfeld M
    J Infect Dis; 2006 Sep; 194(6):734-9. PubMed ID: 16941338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy.
    Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L;
    AIDS; 2015 Mar; 29(5):595-607. PubMed ID: 25715104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
    Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
    Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.
    Engsig FN; Omland LH; Larsen MV; Rasmussen LD; Qvist T; Gerstoft J; Obel N
    HIV Med; 2010 Aug; 11(7):457-61. PubMed ID: 20158527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of antiretroviral therapy for HIV-1-associated tuberculosis.
    Lawn SD; Wood R
    N Engl J Med; 2012 Feb; 366(5):474; author reply 475-6. PubMed ID: 22296084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.